MANASQUAN, N.J., Oct. 6, 2015 /PRNewswire/ -- Fair Rate Funding, a leader in pelvic mesh lawsuit funding, reports a jury verdict in favor of the defendant, Ethicon and their parent company, Johnson and Johnson. The decision marks the first jury verdict in favor of J&J in any trans vaginal pelvic mesh lawsuit to date. The company suffered $21.5 million in damages during losses in four previous pelvic mesh trials. The 12 member jury needed less than 2 days to decide for the Defendant. Cavness v. Kowalczyk et. al., Case # DC-14-04220.
Logo - http://photos.prnewswire.com/prnh/20151006/274615LOGO
The case involved the use of the Gynacare Prosima mesh product, which was implanted in Carol Cavness, an aircraft mechanic who felt a pull in her groin while lifting a heavy object at work. Cavness sought medical treatment and was diagnosed with pelvic organ prolapse. The condition was repaired with a Prosima implant and surgery.
Cavness complained of severe pain and problems walking within 1 month of the procedure and continues to suffer from her physical condition according to the complaint filed 2 years later.
Cavness sued Ethicon, a subsidiary of J&J, for her injuries claiming that the company pushed an unsafe and dangerous product into the marketplace despite knowing that there were safer alternatives.
Plaintiff's attorney offered evidence of Ethicon's own internal memos warning of the product's safety risks. He also argued that there was a less risky alternative to the product's use and that the product was pushed in an effort to obtain more profits for the company with reckless disregard for patient safety.
The Prosima product and other pelvic mesh products have been removed from the marketplace.
Judge Ken Molberg, of the 95th Judicial District in Texas presided over the trial. And there was some apparent confusion as to the legal definitions contained in the jury instructions designed to make it easier for jurors to decide the case. Only 2 jurors reportedly found in favor of Cavness, who was escorted out of the courtroom after hearing the verdict.
"This decision is obviously a blow to plaintiffs suffering from mesh complications," said Paul Coppola, President of Fair Rate Funding, a company which specializes in advancing cash to plaintiffs prior to settlement. "It is encouraging that these cases are making their way through the system and although Ms. Cavness lost this round, victims of pelvic mesh can still remain optimistic that other juries will decide in their favor."
"We understand many plaintiffs need financial help," Coppola continued, "and we intend to give it to them so they can pursue justice."
Since learning of the problems caused by defective pelvic mesh, Fair Rate Funding has worked with thousands of plaintiffs in an effort to secure TV mesh lawsuit funding. These funds are used to help clients pay for ordinary expenses or whatever financial matters arise. There are absolutely no restrictions on the use of the money and no upfront costs to apply.
For more information on how Fair Rate Funding helps victims of Transvaginal Mesh with TV mesh lawsuit funding, visit http://www.fairratefunding.com/transvaginal-mesh-cases/sample-data-articles/transvaginal-mesh-cases.
By offering cash now to help pay for any type of expense such as car loans, rent and mortgage payments, utility payments, personal loans, and daily living expenses, Fair Rate Funding eases some of the financial stress these plaintiffs endure. There are no restrictions on the use of the funds.
Fair Rate Funding specializes in advancing cash now for plaintiffs who are involved in personal injury lawsuits including pelvic mesh. Sometimes referred to as settlement loans or lawsuit loans, settlement funding is NOT a loan transaction but a purchase of a portion of a future recovery. If the lawsuit is unsuccessful for any reason and no money is recovered, the lawsuit funding is not repaid. For answers to frequently asked TV mesh or pelvic mesh lawsuit funding questions, visit: http://www.fairratefunding.com/lawsuit-cash-advance.html
Fair Rate Funding stands ready to assist Trans Vaginal Mesh lawsuit plaintiffs with a TV mesh lawsuit funding, if they already retained an attorney. To learn more about obtaining TV mesh lawsuit funding on your TV Mesh lawsuit in general, visit: http://professionalsettlementfunding.com/transvaginal-mesh-cases/. For more information about TV mesh lawsuit funding as it pertains to Boston Scientific, visit: http://professionalsettlementfunding.com/boston_scientific/.
Fair Rate Funding works diligently to afford lawsuit funding to its applicants and has representatives standing by 24 hours a day, seven days a week to answer questions regarding the lawsuit funding process.
Fair Rate Funding's representatives are working around the clock to make sure each and every client gets the attention they need and to see them through to obtaining a cash advance. Fair Rate Funding is able to offer the lowest rates in the industry and makes the process as seamless as possible.
Fair Rate Funding lawsuit settlement funding programs are not a lawsuit loan or lawsuit loans although they are often referred to as such. A pre-settlement lawsuit cash advance is not a settlement loan or settlement loans because the advance is only repaid if the case is successful. Your attorney will repay your case funding or lawsuit advance ONLY if your case is won or settled.
Fair Rate Funding prides itself on providing the quickest approvals – as soon as 24 hours on most cases, the lowest monthly usage rates – as low as 2.5% per month, and the most attentive customer service in the lawsuit funding industry.
Fair Rate Funding also offers free case evaluations. If you are, at any time, not interested in pursuing lawsuit funding, there are no costs to you and absolutely no obligations.
For more information about lawsuit funding and other services from Fair Rate Funding, simply call a representatives at 888-964-2224 or visit us at http://fairratefunding.com.
SOURCE Fair Rate Funding
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article